The effects are unclear, but medicines acting in the same way can lower DHT, too
Endocrinol.: The maintenance of long-term weight loss after semaglutide withdrawal in obese women with PCOS treated with metformin: a 2-year observational study Medscape: Help Patients Prevent Weight Gain After Stopping GLP-1s
Could chronic oral exposure change long-term safety profiles
You can buy mini blood test from Defy at dirt cheap prices
The identification of dysregulated incretin secretion and action in both obesity and diabetes led to the revolutionary discovery of incretin-based drugs, such as glucagon-like peptide 1 (GLP-1) receptor agonists (RAs) and dual glucose-dependent insulinotropic peptide (GIP)/GLP-1 RAs [24,25,26,27,28]
Your care provider can help you decide if a GLP-1 or any other weight-loss drug is a good fit for you